Clinician-Led Weight Management Service

---

Supporting treatment with Mounjaro® (tirzepatide), Wegovy® (semaglutide), or Orlistat 120 mg

At The Village Pharmacy, we support patients who have been prescribed, or who may be considered for, prescription weight-management medicines as part of a safe, structured, and clinically supervised care plan.

Our service supports treatment with Mounjaro®, Wegovy®, or oral Orlistat 120 mg, offering a range of options to suit different clinical needs, preferences, and budgets. All treatments are supplied only where clinically appropriate, following review and approval by a prescribing clinician.

• Initial consultation
  You will complete a comprehensive health assessment, which is reviewed by a prescribing clinician to determine whether treatment with Mounjaro®, Wegovy®, or Orlistat 120 mg is clinically appropriate.
• 
  
• Ongoing review
  Your progress is monitored throughout treatment. Dose adjustments, continuation, or changes to therapy are made under clinical supervision.
• 
  
• Reserved supply (where appropriate)
  For eligible patients using injectable medicines, we may ring-fence certain doses to help support continuity of care.
• 
  
• Ongoing support
  Our pharmacy team is available throughout your treatment to provide advice, answer questions, and support your weight-management journey.

Our clinician-led weight-management service includes a structured treatment plan, regular reviews, and ongoing pharmacy support.

• 2.5 mg (Weeks 1–4): £225.00
   
• 5 mg (Weeks 5–8): £250.00
   
• 7.5 mg (Weeks 9–12): £299.00
   
• 10 mg (Weeks 13–16): £335.00
   
• 12.5 mg (Weeks 17–20): £350.00
   
• 15 mg (Weeks 21+): £375.00
   

12-Week Subscription Option (Weeks 1–12): £760.00
This discounted subscription ring-fences stock for eligible patients, supporting continuity of care. The price is fixed for the 12-week plan, regardless of market fluctuations. Supply remains subject to clinical approval.

• 0.25 mg: £112.50
   
• 0.5 mg: £125.00
   
• 1 mg: £150.00
   
• 1.7 mg: £175.00
   
• 2.4 mg: £225.00
   

12-Week Subscription Option: £380.00
This subscription offers a cost-effective option for eligible patients and supports continuity of care. Supply is subject to clinical appropriateness and prescribing approval.

Orlistat 120 mg is a non-injectable prescription option that works by reducing dietary fat absorption. It may be suitable for patients who prefer an oral treatment or for whom injectable medicines are not appropriate.

• 120 mg – 84 capsules (4-week supply): £45.00
   
• 120 mg – 168 capsules (8-week supply): £80.00
   

Continued supply is subject to regular review and clinical appropriateness.

• This service applies to patients being considered for, or prescribed, Mounjaro®, Wegovy®, or Orlistat 120 mg.
   
• All medicines are supplied only where clinically appropriate and with approval from a prescribing clinician.
   
• Supply is in line with good practice guidance, relevant formularies, and the requirement for regular clinical reviews before further treatment is issued.
   

⚠️ Please note:
Mounjaro®, Wegovy®, and Orlistat 120 mg are prescription-only medicines. They can only be supplied following a consultation and where clinically appropriate. This service does not guarantee supply of any medicine.